The Boston Scientific Ranger Drug-Coated PTA Balloon Catheter (REF H74939670501510) is a paclitaxel-coated percutaneous transluminal angioplasty balloon designed for the treatment of peripheral arterial disease. This 5 mm x 150 mm device combines a low-profile balloon platform with the proprietary TransPax drug-coating technology to support sustained drug transfer to the vessel wall during angioplasty procedures.
Key Features
Paclitaxel drug coating with a nominal dose density of 2 µg/mm² intended to inhibit neointimal hyperplasia.
TransPax coating technology engineered for efficient drug transfer with low particulate loss.
Balloon working length of 150 mm and nominal diameter of 5 mm.
Low-profile, semi-compliant balloon design for predictable inflation.
Compatible with 0.035 inch guidewires.
Over-the-wire catheter configuration.
Radiopaque markers to support fluoroscopic placement and balloon positioning.
Clinical Applications
Percutaneous transluminal angioplasty of de novo or restenotic lesions in peripheral arteries.
Treatment of atherosclerotic disease in the superficial femoral and proximal popliteal arteries.
Use in lesions where drug-coated balloon angioplasty is selected as part of the endovascular treatment strategy.
Post-dilatation following peripheral stent deployment when clinically indicated by the operating physician.
Product Information
Brand: Boston Scientific
Product Line: Ranger Drug-Coated Balloon (DCB)
Category: Peripheral Balloon Catheters
REF/UPN: H74939670501510
Balloon Diameter: 5 mm
Balloon Length: 150 mm
Drug: Paclitaxel
Dose Density: 2 µg/mm²
Coating Technology: TransPax
Guidewire Compatibility: 0.035 inch
Catheter Type: Over-the-wire PTA balloon
Usable Catheter Length: Not specified in the located sources
Sterility: Sterile, single use